BIOMAT Database Logo BIOMAT Database Logo

The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. 1996

T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Department of Veterinary Science, College of Agriculture, University of Osaka Prefecture, Japan.

125I-labeled botulinum type B neurotoxin was shown to bind specifically to recombinant rat synaptotagmins I and II. Binding required reconstitution of the recombinant proteins with gangliosides GT1b/GD1a. Scatchard plot analyses revealed a single class of binding site with dissociation constants of 0.23 and 2.3 nM for synaptotagmin II and synaptotagmin I, respectively, values very similar to those of the high- (0.4 nM) and low-affinity (4.1 nM) binding sites in synaptosomes. The high-affinity binding of neurotoxin to synaptosomes was specifically inhibited by a monoclonal antibody recognizing with the amino-terminal region of synaptotagmin II. These results suggest that this region of synaptotagmin II participates in the formation of the high-affinity toxin binding site by associating with specific gangliosides.

UI MeSH Term Description Entries
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D003014 Clostridium botulinum A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes (sometimes called antigenic types, or strains) exist, each producing a different botulinum toxin (BOTULINUM TOXINS). The organism and its spores are widely distributed in nature.

Related Publications

T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.
September 2019, Proceedings of the National Academy of Sciences of the United States of America,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Binding of Clostridium botulinum neurotoxin to gangliosides.
July 1986, Journal of biochemistry,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
June 2014, The protein journal,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
January 2007, Microbial pathogenesis,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Biosynthesis of the major brain gangliosides GD1a and GT1b.
October 2012, Glycobiology,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids.
June 1986, FEBS letters,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Interaction between Clostridium botulinum neurotoxin and gangliosides.
March 1980, Biochimica et biophysica acta,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b.
August 2004, Biochemistry,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.
January 2001, Infection and immunity,
T Nishiki, and Y Tokuyama, and Y Kamata, and Y Nemoto, and A Yoshida, and K Sato, and M Sekiguchi, and M Takahashi, and S Kozaki
Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II.
June 2005, The FEBS journal,
Copied contents to your clipboard!